Caremark was found liable in June, and Philadelphia federal court Chief Judge Mitchell Goldberg ordered the company to pay ...

Whistleblower Sarah Behnke's lawsuit leads to $290 million judgment against CVS Caremark for overcharging Medicare on prescription drugs in 2013 and 2014.

Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the ...

A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...

A Pennsylvania judge has ordered CVS to pay $289 million in damages as part of a long-running whistleblower case. | A ...

CVS Health Corp., parent of Hartford-based Aetna Inc., said Friday it has agreed to issue and sell $4 billion in notes.

CVS announced its plan to buy Aetna in 2017. CVS’s board is reportedly considering splitting its legion of retail pharmacies and its Aetna insurance operation into separate companies entirely.

So if CVS, the pharmacy/benefit manager/purveyor of extremely affordable sweet iced tea, ends up spending a reported $69 billion 1 to buy the insurance company Aetna, know that it is not happening ...

The CVS-Aetna move would do just this, and would give the combined organization a competitive market advantage over healthcare providers as soon as integration is complete.

The CVS/Aetna deal reeks of conflicts of interests on multiple levels and is not evidently appealing to shareholders in the short term, as it will take time to digest.

Both stressed that CVS-Aetna will also be better able to serve the aging population in the U.S., which is increasingly relying on the government's Medicare and Medicaid programs for health care.

The current combined balance sheets of Aetna and CVS have over $10 billion in cash and short term investment (source Q3-2017 reports) yet CVS is counting only $4.1 billion of this in the acquisition.